The KRAS gene mutations have been found above in 40 % of colorectal cancers and in 15–25 % of non-small cell lung cancer (NSCLC)—predominantly in patients with adenocarcinoma and smoking history [2, 4–6]. Here, KRAS is linked to colorectal cancer.